GlobalData on MSN9d
EC approves GSK’s Jemperli-chemo combo for endometrial cancerThe EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback